Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2

6/19 In Silico

Lehrer et al., In Vivo, 34:5, 3023-3026, doi:10.21873/invivo.12134
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2

Source PDF Share Tweet

In silico analysis showing ivermectin docking which may interfere with the attachment of the spike to the human cell membrane.

Lehrer et al., 6/19/2020, preprint, 2 authors.

All 113 studies Meta Analysis

Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.

Submit